US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
AnPac Bio Medical Science Company Ltd (ANPC)
AnPac Bio Medical Science Company Ltd (ANPC) ニュース

ANPC

AnPac Bio Medical Science (ANPC)

AnPac Bio Medical Science Company Ltd

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ANPC

1 2 3 4 5 6 7 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/04/22	21 : 03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ANPC	AnPac Bio Medical Science Company Ltd
2024/04/03	05 : 23	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ANPC	AnPac Bio Medical Science Company Ltd
2024/04/02	22 : 01	Edgar (US Regulatory)	Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405	NASDAQ:ANPC	AnPac Bio Medical Science Company Ltd
2024/03/28	05 : 12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ANPC	AnPac Bio Medical Science Company Ltd
2024/03/26	05 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ANPC	AnPac Bio Medical Science Company Ltd
2024/03/26	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ANPC	AnPac Bio Medical Science Company Ltd
2024/03/26	05 : 02	Edgar (US Regulatory)	Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]	NASDAQ:ANPC	AnPac Bio Medical Science Company Ltd
2023/06/16	05 : 02	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:ANPC	AnPac Bio Medical Science Company Ltd
2023/06/16	05 : 01	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:ANPC	AnPac Bio Medical Science Company Ltd
2023/05/23	00 : 28	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:ANPC	AnPac Bio Medical Science Company Ltd
2023/05/20	01 : 55	PR Newswire (US)	Fresh2 Group Ltd. Announces Nasdaq Ticker Symbol Change from 'ANPC' to 'FRES'	NASDAQ:ANPC	AnPac Bio Medical Science Company Ltd
2023/05/18	05 : 03	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:ANPC	AnPac Bio Medical Science Company Ltd
2023/05/17	06 : 00	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:ANPC	AnPac Bio Medical Science Company Ltd
2023/05/17	06 : 00	PR Newswire (US)	Fresh2 Files Annual Report on Form 20-F for Fiscal Year 2022	NASDAQ:ANPC	AnPac Bio Medical Science Company Ltd
2023/05/17	05 : 35	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:ANPC	AnPac Bio Medical Science Company Ltd
2023/05/17	05 : 15	PR Newswire (US)	Fresh2 Reports Fiscal Year 2022 Annual Financial Results	NASDAQ:ANPC	AnPac Bio Medical Science Company Ltd
2023/05/17	05 : 15	PR Newswire (US)	Fresh2 Reports First Quarter of Fiscal Year 2023 Financial Results	NASDAQ:ANPC	AnPac Bio Medical Science Company Ltd
2023/05/11	06 : 11	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:ANPC	AnPac Bio Medical Science Company Ltd
2023/04/11	06 : 23	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:ANPC	AnPac Bio Medical Science Company Ltd
2023/04/10	19 : 04	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:ANPC	AnPac Bio Medical Science Company Ltd
2023/04/07	09 : 10	GlobeNewswire Inc.	Univest Securities, LLC Announces Closing of $3.0 Million Registered Direct Offering for its Client AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC)	NASDAQ:ANPC	AnPac Bio Medical Science Company Ltd
2023/04/07	08 : 15	PR Newswire (US)	AnPac Bio-Medical Science Announces Closing of $3.0 Million Registered Direct Offering	NASDAQ:ANPC	AnPac Bio Medical Science Company Ltd
2023/04/03	22 : 00	PR Newswire (US)	AnPac Bio-Medical Science Enters into Asset Purchase Agreement with Easy Hundred Inc.	NASDAQ:ANPC	AnPac Bio Medical Science Company Ltd
2023/04/03	19 : 17	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:ANPC	AnPac Bio Medical Science Company Ltd
2023/04/01	10 : 06	GlobeNewswire Inc.	AnPac Bio-Medical Science Announces Pricing of $3.0 Million Registered Direct Offering	NASDAQ:ANPC	AnPac Bio Medical Science Company Ltd
2023/03/23	21 : 58	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:ANPC	AnPac Bio Medical Science Company Ltd
2023/03/23	21 : 00	PR Newswire (US)	AnPac Bio-Medical Science Granted Continued Listing by NASDAQ Hearing Panel, Subject to Meeting the Equity Rule on or before July 12, 2023	NASDAQ:ANPC	AnPac Bio Medical Science Company Ltd
2023/03/07	21 : 30	PR Newswire (US)	AnPac Bio Announces Receipt of the First Payment from a Malaysia Customer On a Signed US$1.5 Million Cancer Detection Equipment Purchase Contract	NASDAQ:ANPC	AnPac Bio Medical Science Company Ltd
2023/03/06	22 : 30	PR Newswire (US)	AnPac Bio-Medical Science Announces US$5 Million Private Placement	NASDAQ:ANPC	AnPac Bio Medical Science Company Ltd
2023/02/22	21 : 30	PR Newswire (US)	AnPac Bio Announces Positive Results from its Multi-Year and Multi-Cancer Test Follow-Up Study	NASDAQ:ANPC	AnPac Bio Medical Science Company Ltd

Showing the most relevant articles for your search:NASDAQ:ANPC

1 2 3 4 5 6 7 次へ >>

SG Issuer Sg Issuer Mc D...

Madison Short Term Strat...

Ville de Paris VPARIS3.1...

Medallion Metals

Vontobel Financial Produ...

Jpmorgan Chase Financial...

Societe Generale Effekten

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約